How Daxxify Gained FDA Approval

Gloved hands draw liquid from a small glass vial into a syringe in a treatment room

The smallest sign on a newer wrinkle relaxer is the approval line, because it names who approved the product. This note follows that line for Daxxify.

The approval line

The American Society of Plastic Surgeons states that the FDA approved the drug Daxxify.

The sentence names an agency and a product, which is what a reader should look for on any approval notice.

For the category as a whole, the American Society of Plastic Surgeons page on botulinum toxin is a natural place to begin.

What the drug is

The American Society of Plastic Surgeons describes DaxibotulinumtoxinA-land, or Daxxify, as a new type of neuromodulator derived from botulinum toxin. The source calls it a new type, and that is the detail to hold on to.

What the source confirms

The approval and the description are what the source confirms here. Anything about how a patient would compare Daxxify with another product is a separate question, and it needs its own source. Readers who want to see how another wrinkle relaxer is described can read Healthline's guide to Botox cost, side effects and preparation.

The first check for today

Look for the agency's name on any approval notice you are shown in New Providence. If the notice names only the product, ask where the approval statement was published.